Claim Details

View detailed information about this claim and its related sources.

Back to Claims

Claim Information

Complete details about this extracted claim.

Claim Text
Dr. Andrew Kraftson, a clinical professor at the University of Michigan Medical School who treats patients with obesity, noted that the new study also highlight how many doctors seem to be prescribing these drugs to patients who do not appear to qualify for them.
Simplified Text
Dr. Andrew Kraftson, a clinical professor at the University of Michigan Medical School, noted that the new study highlights many doctors prescribing GLP-1 drugs to unqualified patients.
Confidence Score
1.000
Claim Maker
Dr. Andrew Kraftson
Context Type
News Article
Context Details
{
    "date": "2026-09-22",
    "person": "Dr. Andrew Kraftson",
    "affiliation": "University of Michigan Medical School"
}
Subject Tags
Doctors Medical Ethics GLP-1 Prescribing Practices
UUID
12e139e1-e390-4639-84a7-139a70eec321
Vector Index
✗ No vector
Created
September 25, 2026 at 10:06 AM (2 weeks ago)
Last Updated
September 25, 2026 at 10:06 AM (2 weeks ago)

Original Sources for this Claim (1)

All source submissions that originally contained this claim.

Screenshot of https://nytimes.com/2026/09/22/well/ozempic-glp1-medical-reason.html
GLP-1 Prescriptions for People With No Medical Need Are Climbing
Completed News
7 claims
2 weeks ago
https://nytimes.com/2026/09/22/well/ozempic-glp1-medical-reason.html

A new study analyzing over 92 million U.S. adult medical records found more than 1.1 million people taking GLP-1 medications without an apparent medical reason like obesity or diabetes. Doctors express concern over off-label use, potential risks, and the cultural phenomenon surrounding these drugs.

GLP-1 drugs Ozempic Off-label prescriptions Weight loss drugs Medical ethics Public health Obesity Diabetes

Similar Claims (5)

Other claims identified as semantically similar to this one.